Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL453154 | 1.00 | HCAR2 (0.48) | HCAR2GPR84NAAAFFAR1TSHR | |
| SCHEMBL28253693 | 1.00 | HCAR2 (0.48) | HCAR2GPR84NAAAFFAR1TSHR | |
| SCHEMBL27745640 | 1.00 | HCAR2 (0.48) | HCAR2GPR84NAAAFFAR1TSHR | |
| SCHEMBL8935618 | 1.00 | HCAR2 (0.48) | HCAR2GPR84NAAAFFAR1TSHR | |
| SCHEMBL5718514 | 1.00 | HCAR2 (0.48) | HCAR2GPR84NAAAFFAR1TSHR | |
| SCHEMBL7652872 | 1.00 | HCAR2 (0.48) | HCAR2GPR84NAAAFFAR1TSHR | |
| SCHEMBL27575401 | 1.00 | HCAR2 (0.48) | HCAR2GPR84NAAAFFAR1TSHR | |
| SCHEMBL3960625 | 0.98 | HCAR2 (0.47) | HCAR2GPR84NAAAFFAR1TSHR | |
| Phosphoric Acid SCHEMBL28919710 | 0.92 | LPAR3 (0.50) | HCAR2 | |
| SCHEMBL1196078 | 0.91 | ATM (0.46) | HCAR2GPR84FFAR1TSHRTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180037840-A1 | THERMOCLEAVABLE FRICTION MODIFIERS AND METHODS THEREOF | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2018-02-08 | — | — | US | disclosed |
| US-8124578-B2 | Use of dynamic mixtures for a controlled release of fragrances | FIRMENICH SA (CH) | 2012-02-28 | — | — | US | disclosed |
| EP-1776334-B1 | USE OF DYNAMIC MIXTURES FOR A CONTROLLED RELEASE OF FRAGRANCES | FIRMENICH & CIE (CH) | 2009-10-14 | — | — | EP | disclosed |
| US-20070141011-A1 | USE OF DYNAMIC MIXTURES FOR A CONTROLLED RELEASE OF FRAGRANCES | UNIVERSITE LOUIS PASTEUR (FR) | 2007-06-21 | — | — | US | disclosed |
| EP-1776334-A1 | USE OF DYNAMIC MIXTURES FOR A CONTROLLED RELEASE OF FRAGRANCES | FIRMENICH SA (CH) | 2007-04-25 | — | — | EP | disclosed |
| WO-2006016248-A1 | USE OF DYNAMIC MIXTURES FOR A CONTROLLED RELEASE OF FRAGRANCES | FIRMENICH SA (CH) | 2006-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037840-A1 | THERMOCLEAVABLE FRICTION MODIFIERS AND METHODS THEREOF | F12, F5, F3 | HCAR2 4740/4885GPR84 1550/4885NAAA 3899/4885 |
| US-20070141011-A1 | USE OF DYNAMIC MIXTURES FOR A CONTROLLED RELEASE OF FRAGRANCES | TRPA1, HCN1, HCN4 | HCAR2 153/4885GPR84 608/4885NAAA 571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.